Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

RXRX

RXRX News

Newswire

19:02

Jim Cramer Doubts Recursion Pharmaceuticals, Calls Stock "Horrendous"

16:57

Recursion Pharmaceuticals Director Sells 220,000 Shares at $4.37/Share on December 2, 2023.

22:26

Recursion Pharmaceuticals Inc Sees 15.85% Drop in Short Interest Amid Market Sentiment Shift

03:28

Recursion Pharmaceuticals's Valuation: Undervalued or Overvalued?

19:45

Recursion Pharmaceuticals CEO Gibson Christopher Sells 80,390 Shares in November.

View More

About RXRX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More